Viewing Study NCT01305135


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2025-12-29 @ 1:14 PM
Study NCT ID: NCT01305135
Status: COMPLETED
Last Update Posted: 2017-06-07
First Post: 2011-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module